Article

Ruminant BioTech has launched a CAD$7.6 million ($5.6 million) research program in Canada to validate its methane reduction technology for cattle. The three-year initiative is supported by a CAD$2.8 million grant from the Alberta government, along with CAD$3.4 million from industry partners.

The company will establish its North American base in Calgary, starting the project in August with local colleges and research facilities. The technology, a slow-release bolus that delivers bromoform, can reportedly reduce methane emissions by 75% for over three months. Initial regulatory approval is anticipated in New Zealand by early 2026, with plans to treat 100 million cows globally by 2035.